Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Audited financial results for the quarter and nine months ended December 31 2025 and Interim Dividend for the FY 2025-26 if any
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]